Market Research Report
US Clinical Decision Support Systems Market, Forecast to 2024
|Published by||Frost & Sullivan||Product code||509461|
|Published||Content info||126 Pages
Delivery time: 1-2 business days
|US Clinical Decision Support Systems Market, Forecast to 2024|
|Published: June 24, 2019||Content info: 126 Pages||
A Growing Market with an Opportunity to be More than an Adjunct to the EHR
Clinical Decision Support (CDS) systems are poised to become the user interface of choice for clinical interaction with health IT, ultimately supplanting the HER system as the primary health IT point of interface for clinicians. This is due the fact that CDS began as a way to deliver medical content and patient information to the caregiver. Unlike HER systems that are primarily a way for physicians to document treatment protocols, CDS applications were designed to provide support for physicians during the course of their patient interactions. As a result, CDS systems, from the start, were designed with human factors in mind: how do physicians work, how do they interact with patients, and how do they use information to deliver that treatment? CDS systems, therefore, are much more user friendly and, because they must interface not only with HER systems, but all manner of health IT systems, they are the logical choice to access most health IT systems. This research service explores the dynamics of CDS systems, the market for them, and the primary domains in which they are likely to prove useful.
This study is an update of the very successful 2017 CDS study published by Frost & Sullivan. This study focuses on the US clinical decision support system market. It covers the primary areas of CDS systems subdivided into the primary areas in which CDS systems are currently being applied: clinical knowledge and medical evidence, healthcare analytics, workflow solutions, EHRs, medical devices, data support, clinical surveillance, and CDS platforms. These areas are combined for market growth predictions into: evidence, CDS analytics, workflow, and point of care solutions. Each is projected to grow through the analysis horizon, with especially robust growth in the point of care area.
Overall, the US CDS market is forecast to grow at a CAGR of 9.3% and revenues will top $6.47 billion in the US by 2024. Yet this projection could be conservative when rapid evolutions in medical technology and healthcare regulation are taken into account. In particular, changes in HHS regulations involving interoperability are likely to drive the demand for CDS capabilities, as the regulatory regime becomes much more complex. Additionally, as the Internet of Things (IoT) enables a vast new pool of medical telemetry, CDS will be the key to integrating those new data sources into the clinical work flow.
This research services will be insightful for those looking at understand this rapidly evolving market and the key participants that are driving it.